<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 112 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page111.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=112">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 112 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 112</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=112"><img src="../thumb/112.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Musculo-Skeletal Agents - 4.7.1                                                 2020-04 / 81
       Drug interactions: GI.irrit.assoc.with concom. NSAID’s , Ca sup-  supplem.advis. esp. if intake inadeq./pts.receiv.glucocortic., pts.to   oesophag.abnorm.that may delay empty., inabil. to stand/sit upright
       pl./antacids, oral meds.contain. multival. cations (eg Al, Mg, Fe).  foll. admin.instruct.caref., consid.other poss. osteoporos. caus.other   for at least 30 mins., safety & effic.in childr.not est., pregn.& lactat.
       See also MDR page 74-77.      than oestrog.defic./ageing & glucocorticoid use.  Side effects: Hypersens.reacts.incl.urticar.& angioed., symptomat.
       BONRIX, Accord [P/S]          Drug interactions: Incr.upp.GI adverse events with NSAID’s, addit.  hypocalcaem., headache, uveitis, sclerit., GI disords.incl.abdom.
                                     hypocalcaem.effs.with aminoglycosid., Ca supplem./ antacids/osmot.
                                                                  pain/ oesophag.ulc./-strict./dysphag./oropharyng. ulcerat./gastr.
       Ibandronic acid               laxat. /some food & beverag.may interf.with absorpt. if taken simul-  or duod.ulc.& melaena, rash, prurit., erythema, photosens., Stev.
       Indications: Tumour-induc.hypercalcaem.with/ without metas-  tan., incr.Ca absorpt.with concom. glucocortic.  John.& tox.epiderm.necrolys., musculoskelet.pain, myalg./malaise
       tas., prevent.skelet.complicat.in breast Ca.& bone metastas.pts.  & fev.assoc.with init.of ther.
       req.radiother.                FOSAMAX, MSD [P/S]           Special precautions: Correct hypocalcaem.& Vit.D defic.bef.init.
       (S4) CONC.SOL.FOR IV INFUS, 49/3.2/0583, 0584  Alendronate.  ther., dent.exam.& prevent. dentistry for pts.with concomit.risk fact.
       3000787-001: 2 mg/2 ml, 1 amp, R955,83  Indications: Fract.risk reduct.in postmenopaus. osteoporos.incl.hip &   who should avoid/have indiv.benef/risk assessm.bef. invas.dent.
       3000788-001: 6 mg/6 ml, 1 vial, R2 867,49  spine (vertebra.compress. fract.), prim.hypogonad.osteoporos.in men   proced.as dent.surg.may exacerb.jaw osteonecros., lactose intol.,
       Dosage: Admin.only IV & for sngl.use only.  and vertebral fract.risk reduct.  beverages other than plain water, incl.mineral water may reduc.
       Metastat.bone dis: Recomm.dos.is 6 mg every 3-4 wks.infus over   (S3) ONCE WKLY TABS, 35/3.2/0371  absorpt., supplement. Ca & Vit.D where diet. intake insuff., alert to
       at least 15 mins. Admin.as IV infus.in 100 ml isoton.NaCl/5% dextr.  897302-001: 70 mg, 4, R573,10  S&S of poss.oesophag. react., pts.to follow admin.instruct.carefully,
       sol. Short. infus.(15 mins.) used only for norm./mild ren.funct.impairm.  Dosage: 70 mg once wkly.½ hr.bef.the 1st food, bev./medicat.with a   consid. poss.causes of osteoporos.other than oestrog. defic./ageing.
       Tumour-induc.hypercalcaem: Adults & elderly: Consid.sev.of   full glass of plain water only. Should not lie down for ½ hr.aft.admin.   Drug interactions: Miner./Ca supplem./ antacids & some oral
       hypercalcaem.& tumour type. Gen.low.dos.reqd.in osteolytic bone   Do not chew/suck tabs. Do not admin.at bedt./bef.aris.for the day.  meds.may interfere with absorpt., addit.hypocalcaem.eff.with
       metastas. than in humoral type hypercalcaem. Ensure pt.is adeq.  Contraindications: Oesophag.abnorm., inabil.to stand/sit up-  aminoglycosid.
       hydrat.with 0,9% NaCl bef. admin. Repeat.treatm.poss.in recurr.  right for at least 30 mins., hypocalcaem., sev.ren.insuff., paed.age
       hypercalcaem. /insuffic. effic. Admin.as IV infus. in 500 ml isoton.   group, pregn.& lactat.  OSTEOBON, Cipla Medpro [P/S]
       NaCl/5% dextr.sol.over 2 hrs.  Side effects: Headache, GI eff.incl.oesophag. erosion/ ulcerat.fol-  Alendronate sod.trihydr.equiv.to alendronic acid
       Album.correct.ser.Ca aft.adeq.rehydrat: Sev. hypercalcaem:   low.by strict., gastr./duod.ulc., abdom.pain, dysphag., abdom.dist-  Indications: Postmenopaus.osteoporos.in women to reduc. risk of
       (≥3,5mmol/L or ≥12 mg/dL): 2-4 mg. Mod.hypercalcaem: (&lt;   ent., acid regurgitat., oropharyng.ulcerat., melaen., rash, erythema,   spine & hip fractures.
       3,5mmol/L or &lt;12 mg/dL): 1-2 mg. Do not exceed cumulat.dos.of 6 mg.  musculoskelet.pain, hypersens.reacts. incl.urticar.& angioed., symp-  (S3) TABS-70, A39/3.2/0396
       Rais. ser.Ca lev.reduc.to norm.range in 7 days in most cases.  tomat.hypocalcaem., dizzin., vertigo, uveitis., sclertit., episclerit., joint   705067-001: 70 mg, 4, R277,37
       Contraindications: Biphosphon.hypersens., pregn./ lactat., hy-  swell., localis.osteonecros.of jaw.gen.assoc.with tooth extract.&/loc.  Dosage: 70 mg once wkly.with glass plain water on rising at least
       pocalcaem.                    infect., skin reacts.incl. Stev.-John.syndr.& toxic epiderm.necrolys.,   30 mins.bef.any food/bever./ other medicat. Do not lie down for at
       Side effects: Freq: Infect., parathyroid disord., hypocalcaem., head-  myalg., malaise, asthen., fev., periph.oed., loc.irrit.upper GI.mucosa,   least ½ hr. aft.admin.
       ache, dizzin., dysgeus., cataract, bundle branch block, pharyngit., di-  bld.dyscras., poss. decr.Ca absorpt.in pts.receiv.concom.glucocortic.  Contraindications: Sev.ren.impairm., oesophag. abnorm.that may
       arrh., vomit., dyspeps., GI pain, tooth disord., bone pain, osteoarthrit.,   Special precautions: Concom.HRT (oestrog. with/ without pro-  delay empty., hypocalcaem., inabil. to stand/sit upright for at least
       myalg., arthralg., joint disord., fev., flu-like illn., periph.oed., asthen.,   gest.), act.upper GI prob., Ca & miner.metabol.disturbs.to be treat.  30 mins., safety in childr/ pregn.& lactat.not est.
       thirst. Less freq: Cystit., vaginit., oral candidias., benign skin neo-  bef.init.ther., consid.poss.causes of osteoporos.other than oestrog.  Side effects: Headache, uveitis, GI effs.incl. oesophag. eros./ulcerat.
       plasm, anaem., bld.dyscras., hypersens., bronchosp., angioed., ana-  defic.& ageing., correct.hypocalcaem. bef.initiat.ther., supplement.  follow.by strict., dysphag., oropharyng.ulcerat., gastr./duod.ulc., ab-
       phylact.react./shock, hypophosphataem., sleep disord., anx., affect.   Ca & Vit.D advis.esp. in pts.receiv.glucocortic., if once wkly.dos.miss.   dom.pain, melaena, rash, erythema, musculoskelet.pain, osteone-
       lability, cerebrovasc.disord., nerve root les., amnes., migraine, neu-  take on the morn.aft.rememb.& return.to wkly sched.-do not take 2   cros.of jaw, hypersens.reacts.incl.angioed., poss.decr.Ca absorpt.in
       ralg., hyperton., hyperaesthes., circumor.paraesthes., parosm., ocul.   tabs.on the same day.  pts.receiv.concom. glucocortic.
       inflammat., deafn., hypertens., lymphoed., varic. veins, myocard.is-  Drug interactions: Ca supplem., antacids & some oral meds.may   Special precautions: Dent.exam.& prevent. dentistry for pts.with
       chaem., cardiovasc.disord., palpitat., lung oed., strid., gastroenterit.,   interfere with absorpt.if taken simultan.  concomit.risk fact.who should avoid/have indiv.benef/risk assessm.
       gastrit., mouth ulcerat., dysphag., cheilit., cholelithias., angioneurot.   bef. invas.dent.proced. as dent.surg.may exacerb.jaw osteonecros.,
       oed., skin disord., ecchymos, rash, alopec., Stev.-Johns.syndr., ery-  FOSAVANCE 5600, MSD [P/S]  consid.risk fact.with GI probl. eg. duodenit./dysphag./gastrit./ulc./
       thema multiforme, dermatit. bullous, atypic.subtrohanter.& diaphys.   Alendronate 70 mg, cholecalciferol 140 µg equiv. to Vit.D 5 600 IU  symptomat. oesophag. dis, correct hypocalcaem.& Vit.D defic. bef.init.
       femor.fract., jaw & extern.audit.canal osteonecros., urin.retent., ren.  Indications: Postmenopaus.osteoporos.in women to reduc.fract.  ther., supplement.Ca & Vit.D advis.esp.in pts.receiv.glucocortic., if dos.
       cyst, pelv.pain, chills/ rigors, hypotherm., inj.site pain, weight decr.,   risk incl.vertebra. compress. fract (vertebralcompress.fract.) & to   miss.resume next morn., act.upper GI dis., alert to S&S of poss. oe-
       injury. Freq.unknown: asthma exacerbat.,  help ensure Vit D.adeq.  sophag. react., pts.to follow admin.instruct. carefully, consid.poss.caus-
       Warnings and special precautions: Inadvert. intra-arter./perive-  (S3) TABS. A44/3.2/0350  es of osteoporos.other than oestrog.defic./ageing.& glucocorticoid use.
       nous admin.not recomm., not for use in childr.& adolesc.und.18 yrs.,   721628-001: 4, R308,47  Drug interactions: Ca supplem./antacids & some oral meds.may
       treat hypocalcaem. & other disturbs.of bone & miner. metabol.eff.  Dosage: One tab.once wkly ½ hr.bef.the 1st food/ bev./medicat.with   interfere with absorpt.if taken simultan.
       bef.start.ther., adeq.Ca.& vit.D intake with supplementat.if necess.,   a full glass of plain water only. Should not lie down for 30 mins.aft.
                                            st
       anaphylact.react./ shock report.theref.adeq.facilit.to be avail.&   admin.& till aft.1  food.  OSTEONATE 70 mg, Pharma Dynamics [P/S]
       discont. ther.& instit.appropr.treatm.in occur., monit. ren.funct./  Contraindications: Oesophag.abnorm.which may delay oesophag.  Alendronate monosod.trihydrate
       Ca/phosph.& Mg, no dos. recomm. avail.with sev.hepat.insuffic.,   empty., inabil.to stand/sit upright for at least 30 mins., hypocalcaem.,   Indications: Postmenopaus.osteoporos.in women to reduc.fract.
       avoid overhydrat.in CF/ risk pts., delay new course where unheal.  sev. ren. insuff., pregn.& lactat., paed.age group.  risk incl.spine (vertebral compress) & hip fract.
       open soft tiss.mouth les.pres., dent. exam.bef.init.ther.in pts.with   Side effects: Headache, GI disords.incl. dysphag./ oesophag.eros./  (S3) TABS, 42/3.2/0235
       concom.risk.fact., avoid.invas.dent.proced.dur.ther., consid.poss. os-  ulcerat.follow.by strict., gastr./duod.ulc., abdom.pain, oropharyng. ul-  715987-001: 70 mg, 4, R226,50
       teonecros.of ext.audit.canal if chron.ear. infect. pres., atypic.fract.of   cerat., rash, erythema, musculoskelet.pain, decr. ser.Ca & phosph., hy-  Dosage: Do not chew/suck tab. Admin.on rising with full glass
       subtrochanteric & proxim. femor. shaft.with long term use, prodrom.  persens.reacts.incl. angioed., hypocalcaem.,dizzin., vertigo, dysgeus.,   plain water at least 2 hrs.bef.any food/bever./other med. Remain
       pain of affect. area often assoc.with stress fract.imag. which may be   uveitis., sclerit., episclerit., oesophag.perforat., loc. jaw osteonecros.  in upright posit. for at least 30 min.aft.admin. Allow at least 30
       bilat., diaphys.femor.fract.often. occur. aft.minim./no trauma & may   gen.assoc.with tooth extract./ loc.infect., joint swell., low-energy   min. interv.bef.taking any other oral med. Do not admin. at bedt./
       be.bilat., exam. contralater.fem.where femor.shaft fract.sustain., pts.   femor.shaft fract., .photosens., alopec., Stev. Johns. & tox.epiderm.  bef.arising for the day.
       to report any thigh/hip or groin pain & be eval. for incomplete femur   necrolys., trans.sympt.as in ac.-phase respon (myalg./malaise.fev)   Recomm.dos: 1 tab.once wkly.
       fract., discont.ther.if fract. suspect., broncho-constrict.assoc.with   usually with treatm.init., periph.oed.  Contraindications: Sev.ren.impairm., consid. risk fact.in pres.of GI
       acetylsalicylic acid sensit.asthmat.  Warnings and special precautions: Beverages other than plain   probl.eg. duodenit./ dysphag./ gastrit./ulc./symptomat.oesophag.
       Interactions: Do not mix.with other Ca cont.sols., aminoglycosides   water,incl.miner. water may reduc.absorpt., supplement.Ca & Vit.D   dis., oesophag.abnorm.that may delay empty., inabil. to stand/sit
       may low.ser.Ca lev.& poss.simultan.hypomagnesaem.  advis.if intake inadeq.bear.in mind.that wkly.vit.D intake bas.on 400   upright for at least 30 mins., safety & effic.in childr.not est., safety
                                     and 800 IU dly.dos.is provid., pts. to follow admin.instruct.carefully,   in pregn.& lactat.not est.
       DENSATE 70 mg, Novagen [P/S]  contains sucrose & lact., be alert to S&S of poss.oesphag. react., act.  Side effects: Headache, uveitis, sclerit., GI disords.incl.abdom.pain/
       Alendronic acid               upper GI probl.eg.dysphag./oesophag. dis./ gastrit./duodenit.or ulc.,   dysphag./oesophagit./ oesophag.ulc./regurgit./ melaena/ orophar-
       Indications: Postmenopaus.osteoporos.in women to reduc. risk   concom.NSAID’s, jaw osteonecros.risk fact., discont.ther.on indiv.   yng. ulcerat./gastr.or duod.ulc, rash, erythema, photosens., mus-
       of spine & hip fract., prim./idiopath. osteoporos. & vertebr.fract.  risk vs benef.assessm.in case of jaw osteonecros. developm., clinic.  culoskelet.pain, osteonecros.of jaw, hypersens.reacts.incl.urticar.&
       risk reduct.in men.           managem.plan where invas.dent.surg.reqd., discont.in stress fract.,   angioed., poss.exacerbat.of hypocalcaem.& vit.D defic.
       (S3) TABS, 45/3.2/0581        if dos.miss.take on the morn.aft.rememb. & return.to wkly sched.-do   Special precautions: Correct hypocalcaem.& Vit.D defic.bef.init.
       720516-001: 70 mg, 4, R234,54  not take 2 tabs.on the same day, consid.poss.causes of osteoporos.   ther., dent.exam.& prevent. dentistry for pts.with concom.risk fact.
       Dosage: Admin.with a full glass of plain water at least half an   other than oestrog.defic.& ageing., correct hypocalcaem. & other dis-  who should avoid/have indiv.benef/risk assessm.bef. invas.dent.
       hour bef.first food/beverag./meds.of the day. Remain upright for at   ords.affect.miner. metabol. bef.init.ther., magnit.of hypercalcaem. &/  proced.as dent.surg.may exacerb.jaw osteonecros., wait 30 mins.
       least 30 min.aft. admin. Do not chew/suck tab.or admin.at bedt./   hypercalciuria incr.in presc.of dis.assoc.with unregul.calcitriol over-  aft.treatm.bef.tak. oral meds., beverages other than plain water incl.
       bef. aris.for the day.        product., vit.D absorpt. poss. inadeq.in malabsorpt.  mineral water may reduc.absorpt., supplem. Ca & Vit.D advis.esp.in
       Post-menopaus.osteoporos.in women & prim./ idiopath.os-  Drug interactions: Ca supplem./antacids & some oral meds.may   pts.receiv.glucocortic., consid.benef./risk in pts.with upp.GI dis., alert
       teoporos.in men: 70 mg tab.once wkly.  interfere with absorpt.if taken simultan., vit.D absorpt.imp.by olestra/  to S&S of poss.oesophag.react.& discont.ther.if sympt. worsen,pts.to
       Contraindications: Sev.ren.impairm., oesophag. abnorm.that may   min. oils/orlistat & bile acid sequestr., anticonvuls./ cimetid.& thi-  follow admin.instruct. careful., consid.poss.caus.of osteoporos.other
       delay empty., inabil.to stand/sit upright for at least 30 mins.aft.tak-  azides incr.vit.D catabol.  than oestrog.defic./ageing/glucocortic.use, if once wkly.dos.miss.take
       ing tabs., safety & effic.in childr.not est., safety in pregn.& lactat.   on morn.of rememb.& return to origin.wkly.sched.
       not est., hypocalcaem.        OSTENA 10, 70, Accord [P/S]  Drug interactions: Ca supplem./antacids may interfere with
       Side effects: Rais.liv.enzym., hepatit., hepatocell. damage, bld.  Alendronate sod.equiv.to alendronic acid  absorpt.
       dyscras., ren.fail., atrial fibrillat., symptom. hypocalcaem., hypophos-  Indications: Postmenopaus.osteoporos.in women to reduc.fract.
       phataem., headache, uveit., sclerit., skin reacts., musculoskelet. pain,   risk incl.spine (vertebral compress) & hip fract.  SANDOZ ALENDRONATE 70, Sandoz [P/S]
       myalg., osteonecros.of jaw, synovit., hypersens.reacts.incl.angioed.,   (S3) TABS, 42/3.2/1015, 1016  Alendronate sod.equiv.to alendronic acid
       malaise, fev., oesophagit., oesophag.ulc./eros./strict., poss. decr. Ca/  715712-001: 10 mg, 28, R224,62  Indications: Postmenopaus.osteoporos.in women to reduc.fracture
       phosph. absorpt.in pts.receiv.concom. glucocortic., GI disords.incl.  715713-001: 70 mg, 4, R206,75  risk incl.spine & hip fractures
       malaena/oesophag. Ca/perforat./oropharyng.ulc.  Dosage: Admin.with full glass plain water on rising at least 2 hrs.  (S3) TABS-70, A40/3.2/0515
       Special precautions: Dent.exam.& prevent. dentistry for pts.with   bef.any food/bever./other medicat. Remain in upright posit.for at   709760-001: 70 mg, 4, R256,97
       concomit.risk fact., avoid invas. dent.proced., indiv.benef/risk as-  least 30 min.aft.admin. Allow at least 30 min. interv.bef. taking any   Dosage: 70 mg once wkly. with full glass plain water on rising at
       sessm.bef. invas. dent.proced.as dent.surg.may exacerb.jaw osteone-  other oral medicat.  least 2 hrs.bef.any food/ bever./ other medicat. Remain in upright
       cros., cons.benef./risk fact.with upp.GI dis. eg. duodenit./ dysphag./  Ostena 10: Recomm.dos.10 mg once dly.  posit.for at least 30 min.aft.admin. Allow at least 30 min. interv.bef.
       gastrit./ulc./symptomat. oesophag. condits.& potent.for underly.dis.   Ostena 70: Recomm.dos 70 mg once wkly.  taking any other oral medicat.
       worsen., correct hypocalcaem.& Vit.D defic. bef. init. ther., alert to   Contraindications: Sev.ren.impairm., consid. risk fact.in pres.of GI   Contraindications: Sev.ren.impairm., consid. risk fact.in pres.of GI
       S&S of poss.oesophag.react.& discont. ther.if necess., Ca & Vit.D   probl.eg.duodenit./ dysphag./ gastrit./ulc./symptomat.oesophag. dis.,   probl.eg. duodenit./ dysphag./ gastrit./ulc./symptomat.oesophag.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page111.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page107.html">107</a>&nbsp;&nbsp;&nbsp;<a href="page108.html">108</a>&nbsp;&nbsp;&nbsp;<a href="page109.html">109</a>&nbsp;&nbsp;&nbsp;<a href="page110.html">110</a>&nbsp;&nbsp;&nbsp;<a href="page111.html">111</a>&nbsp;&nbsp;&nbsp;<a href="page112.html">112</a>&nbsp;&nbsp;&nbsp;<a href="page113.html">113</a>&nbsp;&nbsp;&nbsp;<a href="page114.html">114</a>&nbsp;&nbsp;&nbsp;<a href="page115.html">115</a>&nbsp;&nbsp;&nbsp;<a href="page116.html">116</a>&nbsp;&nbsp;&nbsp;<a href="page117.html">117</a>
             </td>
             <td width="35%"><a href="page113.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page113.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
